EXEL - Financial Reports List - Exelixis, Inc. - IntrinsicAlpha

Exelixis, Inc. EXEL

Healthcare - Biotechnology - NASDAQ - US

$ 42.86

-1.44 %

$ 11.7 B

Market Cap

19.96

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-04-04	30.62%	327.73%	534.24%
Quarterly Report	Q4	8-K	2025-01-03	18.16%	63.55%	99.55%
Annual Report	FY	10-K	2025-01-03	18.49%	150.89%	253.82%
Quarterly Report	Q3	8-K	2024-09-27	14.33%	11232.66%	873.90%
Quarterly Report	Q2	8-K	2024-06-28	35.61%	178.54%	254.98%
Quarterly Report	Q1	8-K	2024-03-29	4.02%	-6.77%	34.07%
Quarterly Report	Q4	8-K	2023-12-29	13.15%	383.43%	270.12%
Annual Report	FY	10-K	2023-12-29	13.60%	13.98%	-15.19%
Quarterly Report	Q3	8-K	2023-09-29	14.62%	-98.58%	-21.28%
Quarterly Report	Q2	8-K	2023-06-30	12.02%	14.87%	-7.00%

1